A carregar...
Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure
AIMS: Large‐scale clinical trials have demonstrated clinical benefits of sacubitril–valsartan in symptomatic heart failure with reduced ejection fraction patients (PARADIGM‐HF), with potential benefits in patients hospitalized for acute decompensated heart failure (ADHF) (PIONEER‐HF) and fewer benef...
Na minha lista:
| Publicado no: | ESC Heart Fail |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7261587/ https://ncbi.nlm.nih.gov/pubmed/32167679 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12676 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|